IMVT•benzinga•January 13, 2025 at 01:38 PM

Immunovant Announces $450M Private Placement Of 22.5M Shares Of Common Stock At A Purchase Price Of $20.00 Per Share To Three Institutional Accredited Investors In A Private Investment In Public Equity

No summary available.

Read the full article from the original source for complete details and context.

Article published on January 13, 2025 by benzinga